Stockscreener 앱 받기
0.00
100.00%
-0.0003
전일 마감가:
$0.0003
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
$389.80K
순이익/손실:
$-5.33M
주가수익비율:
0.00
EPS:
-2.4117
순현금흐름:
$-4.78M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.0003
52주 변동 폭
$0.00
$0.6407
Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile
Compare LIPO vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIPO
Lipella Pharmaceuticals Inc
|
0.00 | 0 | 389.80K | -5.33M | -4.78M | -2.4117 |
VRTX
Vertex Pharmaceuticals Inc
|
548.05 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
834.04 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,039.78 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.13 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스
Lipella Pharmaceuticals Inc. Revenue Breakdown – OTC:LIPO - TradingView
Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4 - TradingView
Price to book forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Enterprise value to EBIT forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Price to sales forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Enterprise value to EBITDA forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Lipella Pharmaceuticals Inc (LIPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lipella Pharmaceuticals Inc. (LIPO) Stock Price | Live Quotes & Charts | PINL - StocksToTrade
Lipella Pharmaceuticals Inc (LIPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Institutional Confidence - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lipella Pharmaceuticals Inc. (LIPO) Eps Diluted (TTM) - Zacks Investment Research
TradingKey - TradingKey
Market Wrap: Is Lipella Pharmaceuticals Inc stock good for income investorsForecast Cut & Smart Investment Allocation Insights - baoquankhu1.vn
Hedge Fund Moves: Whats the beta of Lipella Pharmaceuticals Inc stockWeekly Investment Report & Risk Controlled Swing Alerts - baoquankhu1.vn
Options Flow: Can Lipella Pharmaceuticals Inc deliver consistent EPS growth2026 Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Insider Trends: Is Lipella Pharmaceuticals Inc forming a breakout pattern2026 Momentum & Real-Time Volume Spike Alerts - baoquankhu1.vn
1080highp-h264Dailyhunt - Dailyhunt
Lipella Pharmaceuticals files for bankruptcy protection four years after going public - WPXI
Stock List: Research Stocks from Around the World - GuruFocus
Pittsburgh biotech company Lipella Pharmaceuticals files for bankruptcy protection - TribLIVE.com
Future Perspectives: Key Trends Shaping the Lichen Planus Market Until 2030 - openPR.com
Sell Signal: Is Lipella Pharmaceuticals Inc forming a breakout pattern2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Lipella Pharmaceuticals Begins Chapter 11 Bankruptcy Restructuring Process - TipRanks
Biotech Company Files for Chapter 11 Bankruptcy, Plans Asset Sale - WhatNow
Lipella Pharmaceuticals Files for Chapter 11 Bankruptcy - National Today
Entry Recap: Will ELAB benefit from rising consumer demandAnalyst Upgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
Tenaris Files its 2025 Annual Report and its Annual Report on Form 20-F - The Manila Times
US Senators send letter to SEC, requesting explanation for former enforcement chief's brief tenure and reversal of decisions on crypto cases - Bitget
Legal risks combined with AI's high costs cause Meta's market value to evaporate by $280 billions, raising concerns about tobacco industry-style risks - Bitget
Lipella Pharmaceuticals Inc plans to file customary "first day" relief motions with the court. - Bitget
Tims China Announces Q4 and Full Year 2025 Results Conference Call - The Manila Times
Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11 - The Manila Times
Dropship China Pro Expands US Fulfillment Warehouse Operations to Meet Growing Demand for Faster E-commerce Delivery - The Manila Times
Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11 - TradingView — Track All Markets
Lipella Pharmaceuticals files for Chapter 11 ba... - Pluang
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised - GlobeNewswire
Lipella Pharmaceuticals Inc.: Fundamental Analysis and Financial Ratings | | US53630L2097 - marketscreener.com
Patterns Watch: Whats the beta of Lipella Pharmaceuticals Inc stockRecession Risk & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Decliners Report: Can Lipella Pharmaceuticals Inc maintain its current growth rate2026 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn
Price Action: Can Lipella Pharmaceuticals Inc grow without external fundingWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Chipmakers Recap: What is the next catalyst for Lipella Pharmaceuticals IncJuly 2025 Opening Moves & Target Return Focused Stock Picks - baoquankhu1.vn
Dip Buying: How does Lipella Pharmaceuticals Inc score in quality rankingsPortfolio Update Summary & Stock Timing and Entry Methods - baoquankhu1.vn
LIPO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Covering: Is Lipella Pharmaceuticals Inc a strong candidate for buy and holdJuly 2025 Selloffs & Weekly Market Pulse Updates - baoquankhu1.vn
Will Lipella Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Gainers & Stock Timing and Entry Methods - mfd.ru
Lipella Pharmaceuticals Inc (LIPO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
1.07%
자본화:
|
볼륨(24시간):